WallStreetZenWallStreetZen

AnalystsDavid Stanton
David Stanton's Stock Forecasts

Sectors:
Healthcare
Industries:
Biotechnology
Analyst Ranking
Top 39%
#2111 out of 5511 analysts
Average Return
+89.13%
Win Rate
67%2 out of 3
Risk vs Reward
Poor
Good

David Stanton's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Mesoblast LtdMESO
+166.31%$6.47$17.23
2024-08-29 -
2024-12-23
Strong Buy
Mesoblast LtdMESO
+109.32%$3.22$6.74
2023-08-31 -
2024-08-30
Strong Buy

David Stanton Analyst Color

Get additional color on David Stanton's coverage of popular stocks

David Stanton's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Mesoblast LtdMESO
6Strong BuyN/AN/AUpgrades
10 months ago
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.